{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:32:34Z","timestamp":1793809954663,"version":"4.6.1"},"reference-count":38,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","award":["TURSP (2020\/171)"],"award-info":[{"award-number":["TURSP (2020\/171)"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Psychotropic medication use is rising among children with autism spectrum disorders (ASD) in Saudi Arabia. Two hundred ninety-three parents of children diagnosed with ASD completed a parental concerns questionnaire (PCQ) online to examine children\u2019s family socio-demographics, health conditions and comorbidities, and past and current exposure to psychotropic medication as prescribed by their primary doctor. Findings revealed that more than one-third of the parents (39.08%) reported that their children were using medications at the time of the survey; risperidone (53%), methylphenidate (30%), and valproic acid (9%) were the most commonly used. A smaller number of parents stated that their children had previously used medications (16.09%). The most often prescribed drugs among this group were risperidone (45%), followed by methylphenidate (32%) and valproic acid (17%). The variables that showed a statistically significant association with the current use of psychotropic drugs were the child\u2019s age (OR = 1.25, 95% CI: 1.12, 1.40, p &lt; 0.001), presence of comorbidities (OR = 7.75, 95% CI: 3.48, 17.24, p &lt; 0.001), communication difficulties (OR = 1.79, 95% CI: 1.09, 2.95, p &lt; 0.021), and anxiety symptoms (OR = 1.70, 95% CI: 1.00, 2.87, p &lt; 0.049). Similarly, the child\u2019s age (OR = 1.23, 95% CI: 1.08, 1.40, p &lt; 0.002) and presence of comorbidities (OR = 2.83, 95% CI: 1.16, 6.29, p &lt; 0.022) showed statistically significant associations with previous use.<\/jats:p>","DOI":"10.3390\/children9070966","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T23:59:22Z","timestamp":1656460762000},"page":"966","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychotropic Medications Use among Children with Autism in Saudi Arabia"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-0960","authenticated-orcid":false,"given":"Shuliweeh","family":"Alenezi","sequence":"first","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alnemary","sequence":"additional","affiliation":[{"name":"Department of Special Education, College of Education, Taif University, Taif 21944, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Alamri","sequence":"additional","affiliation":[{"name":"Department of Child Psychiatry, King Abdullah Specialist Children Hospital, Riyadh 14611, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal","family":"Albakr","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamees","family":"Abualkhair","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Alnemary","sequence":"additional","affiliation":[{"name":"Autism Center of Excellence, Riyadh 12713, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MOP.0b013e32834cf082","article-title":"Behavioral interventions in children and adolescents with autism spectrum disorder: A review of recent findings","volume":"23","author":"Dawson","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/CHI.0b013e3181bfd669","article-title":"Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial","volume":"48","author":"Aman","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/cap.2009.0121","article-title":"Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6\u201317 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study","volume":"21","author":"Marcus","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in Children with Autism and Serious Behavioral Problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/acps.12644","article-title":"Use of psychotropic drugs in patients with autism spectrum disorders: A systematic review","volume":"135","author":"Jobski","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881117741766","article-title":"Autism spectrum disorder: Consensus guidelines on assessment, treatment and re-search from the British Association for Psychopharmacology","volume":"32","author":"Howes","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref_7","first-page":"250","article-title":"Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders","volume":"48","author":"Lamy","year":"2018","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"ref_8","unstructured":"Aljarallah, A., Alwaznah, T., Alnasari, S., and Alhazmi, M. (2014, June 13). A Study of Autism and Developmental Disorders in Saudi Children. Riyadh: Report, King Abdulaziz City for Science and Technology. Available online: http:\/\/www.kacst.edu.sa."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103054","DOI":"10.1016\/j.ajp.2022.103054","article-title":"Prevalence of autism spectrum disorder among Saudi children between 2 and 4 years old in Riyadh","volume":"71","author":"AlBatti","year":"2022","journal-title":"Asian J. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/1362361316664868","article-title":"Services for children with Autism in the Kingdom of Saudi Arabia","volume":"21","author":"Alnemary","year":"2016","journal-title":"Autism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2989\/17280583.2013.767265","article-title":"Prevalence and patterns of medication use in children and adolescents with autism spectrum disorders in the Western Cape, South Africa","volume":"25","author":"Louw","year":"2013","journal-title":"J. Child Adolesc. Ment. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ridd.2011.10.001","article-title":"Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: Perspective from a developing country","volume":"33","author":"Memari","year":"2012","journal-title":"Res. Dev. Disabil."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psychres.2019.04.013","article-title":"Prevalence and Predictors of Psychotropic Medication Use in adolescents and Adults with Autism Spectrum Dis-order In Italy: A Cross-Sectional Study","volume":"276","author":"Brondino","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1025883612879","article-title":"Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio","volume":"33","author":"Aman","year":"2003","journal-title":"J. Autism Dev. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/104454602762599853","article-title":"Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina","volume":"12","author":"Aman","year":"2002","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_16","unstructured":"(2022, June 05). Determining Poverty Line and Sufficiency Line. Available online: https:\/\/kkf.org.sa\/media\/qfahczvz\/1-determining-poverty-line-and-sufficiency-line-2017.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pediatrneurol.2007.04.013","article-title":"Developmental and Behavioral Questionnaire for Autism Spectrum Disorders","volume":"37","author":"McGrew","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40489-017-0104-6","article-title":"Autism Research: Where Does the Arab World Stand?","volume":"4","author":"Alnemary","year":"2017","journal-title":"Rev. J. Autism Dev. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/aur.2040","article-title":"Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom","volume":"11","author":"Houghton","year":"2018","journal-title":"Autism Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1590\/1516-4446-2013-S104","article-title":"Autism spectrum disorders: An overview on diagnosis and treatment","volume":"35","author":"Brentani","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00213-013-3140-7","article-title":"Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care","volume":"231","author":"Murray","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"617395","DOI":"10.3389\/fpsyt.2020.617395","article-title":"Editorial: Comorbidity and Autism Spectrum Disorder","volume":"11","author":"Casanova","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","article-title":"Psychiatric Disorders in Children with Autism Spectrum Disorders: Prevalence, Comorbidity, and Associated Factors in a Population-Derived Sample","volume":"47","author":"Simonoff","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/ppe.12413","article-title":"Prevalence of Autism Spectrum Disorders with and without Intellectual Disability by Gestational Age at Birth in the Stockholm Youth Cohort: A Register Linkage Study","volume":"31","author":"Xie","year":"2017","journal-title":"Paediatr. P\u00e9rinat. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1528-1167.2007.01399.x","article-title":"The autism-epilepsy connection","volume":"48","author":"Levisohn","year":"2007","journal-title":"Epilepsia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2217\/npy.11.62","article-title":"Treatment of comorbid anxiety and autism spectrum disorders","volume":"1","author":"Nadeau","year":"2011","journal-title":"Neuropsychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rasd.2014.03.008","article-title":"Behavior problems among school-aged children with autism spectrum disorder: Associations with children\u2019s communication difficulties and parenting behaviors","volume":"8","author":"Boonen","year":"2014","journal-title":"Res. Autism Spectr. Disord."},{"key":"ref_28","first-page":"27","article-title":"Pharmacotherapy of Aggression in Children and Adolescents: Efficacy and Effect Size","volume":"15","author":"Pappadopulos","year":"2006","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2147\/NDT.S84585","article-title":"Aggression in autism spectrum disorder: Presentation and treatment options","volume":"12","author":"Fitzpatrick","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"113321","DOI":"10.1016\/j.psychres.2020.113321","article-title":"Multimorbidity and Psycho-tropic Polypharmacy among Participants with Autism Spectrum Disorder with Intellectual Disability","volume":"292","author":"Espadas","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ariefdjohan, M., Lee, Y., Stutzman, D., LeNoue, S., and Wamboldt, M. (2021). The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study. Pediatric Rep., 13.","DOI":"10.3390\/pediatric13030049"},{"key":"ref_32","first-page":"526","article-title":"Autism Spectrum Disorder: Main Problem Waiting for Solution in Kingdom of Saudi Arabia","volume":"8","author":"Zeina","year":"2014","journal-title":"Int. J. Med. Health Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/NDT.S151802","article-title":"Risperidone for children and adolescents with autism spectrum disorder: A systematic review","volume":"14","author":"Maneeton","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/cap.2011.0057","article-title":"Prevalence and Correlates of Psychotropic Medication Use in Adolescents with an Autism Spectrum Disorder with and without Caregiver-Reported Attention-Deficit\/Hyperactivity Disorder","volume":"21","author":"Frazier","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/NDT.S118304","article-title":"Assessment of suicidality in children and adolescents with diagnosis of high functioning autism spectrum disorder in a Turkish clinical sample","volume":"12","author":"Demirkaya","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_36","first-page":"22","article-title":"Prevalence of psychiatric disorders in adults with autism spectrum disorder: A systematic review and meta-analysis","volume":"59","author":"Alviani","year":"2018","journal-title":"Res. Autism Spectr. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112679","DOI":"10.1016\/j.psychres.2019.112679","article-title":"Prevalence of autism spectrum disorder in Asia: A systematic review and meta-analysis","volume":"284","author":"Qiu","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_38","unstructured":"(2022, May 01). Autismspeaks.org. Aggressive and Challenging Behaviors Tool Kit. Available online: https:\/\/www.autismspeaks.org\/sites\/default\/files\/2018-08\/Challenging%20Behaviors%20Tool%20Kit.pdf."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/9\/7\/966\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:46Z","timestamp":1760139586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/9\/7\/966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["children9070966"],"URL":"https:\/\/doi.org\/10.3390\/children9070966","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]}}}